Cite
HARVARD Citation
Massaro, M. et al. (n.d.). Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes. Pharmacological research. pp. 125-136. [Online].